An exploratory review of the electroacupuncture literature: clinical applications and endorphin mechanisms

This study is a comprehensive bibliometric analysis of the electroacupuncture (EA) literature published between 1975 and 2012, exploring three main aspects: publication trends, clinical conditions treated, and endorphin mechanisms. The author conducted systematic PubMed searches to examine how EA has evolved in clinical practice and experimental research. The analysis revealed that of the 2,916 clinical acupuncture studies identified, 18.8% used EA, while in the 3,344 animal studies, 48.1% employed this technique. This demonstrates that EA plays a more prominent role in experimental research than in clinical practice.

A significant finding was the shift in research focus over time: initially, about 60% of EA studies focused on pain treatment, but this proportion declined to roughly 25% in the most recent decade, indicating expansion into other medical conditions. The conditions most commonly treated with EA include musculoskeletal disorders (90 studies), intra- and postoperative analgesia (64), neurology (47), obstetrics and gynecology (32), gastroenterology (32), psychiatry (26), and genitourinary disorders (16). Analysis of endorphin mechanisms revealed important differences between manual acupuncture and EA. Whereas 34% of manual acupuncture studies did not confirm involvement of endogenous opioid mechanisms, only 17% of EA/TEAS studies were negative for these mechanisms.

This suggests that EA, by providing more intense and prolonged stimulation, is more effective at activating natural endorphin systems. The study also identified that different EA frequencies activate different opioid mechanisms: low frequency (1-7 Hz) is associated with β-endorphin release in the arcuate nucleus of the hypothalamus via μ-opioid receptors, while high frequency (≥80 Hz) promotes dynorphin release in the spinal cord via κ-opioid receptors. This frequency specificity has important implications for clinical protocols. The research demonstrated that increases in endorphin levels are more likely in the central nervous system than in the bloodstream in response to EA, suggesting that primary effects occur locally in the brain and spinal cord.

Limitations of the study include the restriction to PubMed, potentially excluding many non-English studies, and possible publication bias favoring positive results. Methodologically, some studies may have used inadequate stimulation parameters or insufficient doses of opioid antagonists to detect endorphin mechanisms. The work also identified confounding factors that may affect outcomes, including sex differences, individual pre-existing endorphin status, variations in responsiveness, presence of disease, and situational context such as stress-induced analgesia. Despite these limitations, the study provides robust evidence that EA is more consistent than manual acupuncture in activating endogenous opioid mechanisms.

This may partly explain why EA is often preferred in research settings and for certain clinical conditions. The clinical implications are substantial: EA offers a theoretical advantage over manual acupuncture for conditions in which endorphin mechanisms are important, and different frequencies can be selected based on the desired mechanisms. The continued growth of the EA literature, especially for non-pain conditions, suggests broader therapeutic potential than historically recognized. The study concludes that, although both manual acupuncture and EA can release endorphins, the evidence is more consistent and convincing for EA, particularly with low-frequency stimulation.

This supports the growing use of EA in research and suggests that evidence-based clinical protocols should consider specific frequency parameters to optimize therapeutic outcomes.